Merck Sharp & Dohme Corp. v. Gnosis S.p.A.

808 F.3d 829·2015

What the Court Decided

Federal Circuit case applying patent law to pharmaceutical inventions and addressing scope of patentable subject matter in the drug development context.

Full entry not yet generated. Run npm run enrich-precedents to add it.

Cited In

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

2025 Term · 24-889

Federal Circuit decision addressing patent law standards in pharmaceutical cases; directly relevant as a Circuit precedent on issues likely discussed in this appeal.